62 results
424B3
SRZN
Surrozen Inc
10 May 23
Prospectus supplement
4:47pm
pandemic or events associated with the pandemic;
failure of us or Boehringer Ingelheim International GmbH to adequately perform under the Collaboration … available, including restrictions related to the COVID-19 pandemic and the conflict between Russia and Ukraine.
In addition, our future clinical trials
424B3
SRZN
Surrozen Inc
7 Apr 23
Prospectus supplement
5:20pm
of the COVID-19 pandemic or events associated with the pandemic;
failure of us or Boehringer Ingelheim International GmbH to adequately perform under … patients, principal investigators or staff or clinical site available, including restrictions related to the COVID-19 pandemic and the conflict
POS AM
SRZN
Surrozen Inc
31 Mar 23
Prospectus update (post-effective amendment)
9:09am
of a clinical trial or manufacturing site;
delays as a result of the COVID-19 pandemic or events associated with the pandemic;
failure of us … restrictions related to the COVID-19 pandemic and the conflict between Russia and Ukraine.
In addition, our future clinical trials will compete
424B5
nv5ttnjf11h8q5rz
21 Dec 22
Prospectus supplement for primary offering
6:05am
S-3
9assibuhr6ssn6g
9 Dec 22
Shelf registration
5:31pm
8-K
EX-99.1
n4jxjcj kb
15 Nov 22
Surrozen Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:12pm
424B3
j0veohw
15 Nov 22
Prospectus supplement
6:30am
424B3
1my4pdi15uuhxil
15 Nov 22
Prospectus supplement
6:30am
424B3
btijoj44
24 Aug 22
Prospectus supplement
7:43pm
424B3
yi7r3
23 Aug 22
Prospectus supplement
5:13pm
8-K
EX-99.1
n7dl3qht
11 Aug 22
Surrozen Reports Second Quarter 2022 Financial Results
12:43pm
424B3
ygc5z923x3nkfinm
11 May 22
Prospectus supplement
8:04pm
424B3
me7fruk jlkxb258x
11 May 22
Prospectus supplement
8:02pm
8-K
EX-99.1
5iqvl55
11 May 22
Surrozen Reports First Quarter 2022 Financial Results
8:16am